Nasdaq

Cochlear announces FDA approval and FDA clearance of first-of-its-kind Remote Care capabilities for Nucleus and Baha Systems

LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
Nasdaq

FDA expedites approval of Cochlear's Remote Check solution for cochlear implants

CENTENNIAL, Colo., April 7, 2020 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April 2 ...
FierceBiotech

In a first, FDA allows remote tweaking of cochlear implants

The FDA has approved the remote programming of cochlear implants via a telemedicine platform, freeing patients with severe to profound hearing loss from the need to visit specialized centers to get ...
MobiHealthNews

FDA approves remote reprogramming feature for cochlear implant

The FDA has approved hearing implant maker Cochlear Limited’s submission for a new remote feature that would allow specialists to perform follow-up programming on a patient’s cochlear implant remotely ...
The Globe and Mail

Cochlear Limited’s Remote Care Study: A Potential Game-Changer in Hearing Implant Management

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear Limited is conducting a study ...